Theranostics in Developing Countries: Addressing Challenges and Potentials from Training to Practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Theranostics in Developing Countries: Addressing Challenges and Potentials from Training to Practice

Published:2023-09 Issue:03 Volume:22 Page:171-173
ISSN:1450-1147
Container-title:World Journal of Nuclear Medicine
language:en
Short-container-title:World J Nucl Med

Author:

Al-Ibraheem Akram¹²³^ORCID

Affiliation:

1. Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan

2. Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University of Jordan, Amman, Jordan

3. Arab Society of Nuclear Medicine (ARSNM), Amman, Jordan

Publisher

Georg Thieme Verlag KG

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0043-1774733.pdf

Reference14 articles.

1. Promotion of nuclear medicine-related sciences in developing countries;D S Lee;Nucl Med Mol Imaging,2019

2. Theranostic approaches in nuclear medicine: current status and future prospects;L Filippi;Expert Rev Med Devices,2020

3. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer;O Sartor;N Engl J Med,2021

4. 177Lu-Dotatate plus long-acting octreotide versus high–dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial;J R Strosberg;Lancet Oncol,2021

5. Nuclear theranostics in Asia: in vivo companion diagnostics;D S Lee;Nucl Med Mol Imaging,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A New Era for PET/CT: Applications in Non-Tumorous Renal Pathologies;Journal of Clinical Medicine;2024-08-07

2. Analysis of Molecular Imaging and Laboratory Baseline Biomarkers in PSMA-RLT: Whole-Body Total Lesion PSMA (TLP) Predicts Overall Survival;Cancers;2024-07-26

3. Efficacy and safety of rechallenge [177Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study);European Journal of Nuclear Medicine and Molecular Imaging;2024-07-15

4. Radiotheranostics Global Market and Future Developments;Seminars in Nuclear Medicine;2024-07

5. Six country vignettes: Strengthening radiotherapy and theranostics;Journal of Cancer Policy;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3